IndraLab

Statements


Doxorubicin increases the amount of CYLD. 2 / 3
| 2

reach
"Doxorubicin, which is a common agent used for transarterial chemoembolization procedures in HCC, induced CYLD expression in various subcellular compartments, including nucleoli."

reach
"Induction of CYLD expression by doxorubicin treatment led to increased cytoplasmic and nuclear expression of CYLD."